Transdermal Drug Delivery News

1. Nutriband With Kindeva Drug Delivery Select Aversa Fentanyl Abuse Deterrent Formulation For Commercial Scale Manufacturing Process Development 4/4/2023

   Nutriband Inc. with Kindeva Drug Delivery (“Kindeva”) have selected the target AVERSA formulation to take forward into commercial scale manufacturing process development for the Company’s patented lead product, AVERSA Fentanyl, an abuse-deterrent fentanyl transdermal system.

2. Windgap Medical Appoints Aaron Mann As CEO, Michael Samar As CFO 2/13/2023

   Both bring significant industry tenure and experience to their roles, and with Windgap Co-Founder Brent Buchine, will lead the company's continued growth in the field of complex injectable drug delivery solutions.

3. West Makes Minority Investment In Dublin-Based Latch Medical, A Developer Of Vaccine And Biologics Delivery Platforms 8/15/2022

   West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has made a strategic investment in Latch Medical, a Dublin-based leader in next-generation vaccine and biologics delivery technology that is pioneering a new approach to intradermal delivery.